Sandra Milligan

President of Clinical and Commercial Operations • Aspira Women's Health

Dr. Sandra Milligan is an accomplished and dynamic C-suite pharmaceutical executive who integrates a unique background, diverse professional experience and leadership to drive results. With over 20 years of experience in large (Amgen, Genentech, Merck), mid (Organon) and small-cap (Aspira Women’s Health) companies, Sandra is a proven professional building and propelling forward product portfolios aligned with commercial and manufacturing priorities. Sandra’s experience expands across therapeutic areas and modalities, including oncology and non-oncology disease areas, small molecules, diagnostics, biologics and vaccines, reflected by stage gate advancement, new market approvals and product line extensions. Sandra received her medical degree from George Washington University, her law degree from Georgetown University and served in the Army medical corps.